Aachen, Germany

Steffen Koschmieder

This inventor holds 1 USPTO granted patent. Top assignee: Forschungszentrum Julich Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steffen Koschmieder. Retrieved from https://idiyas.com/inventor/steffen-koschmieder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Steffen Koschmieder: Innovator in Bromodomain Inhibitors

Introduction

Steffen Koschmieder is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of bromodomain inhibitors. His work focuses on creating compounds that can be utilized in the treatment of disorders associated with bromodomains, including cancer.

Latest Patents

Steffen Koschmieder holds a patent for bromodomain inhibitors. The invention relates to compounds according to the general formula (1), and to their use in the production of a medicament, especially for treating disorders associated with bromodomains, such as cancer. This patent highlights his innovative approach to addressing critical health challenges.

Career Highlights

Koschmieder is affiliated with Forschungszentrum Jülich GmbH, where he conducts research and development in the field of medicinal chemistry. His work at this esteemed research center has positioned him as a key figure in the advancement of therapeutic compounds.

Collaborations

He collaborates with talented colleagues, including Giulia Rossetti and Jan-Hendrik Schöbel. Their combined expertise enhances the research efforts at Forschungszentrum Jülich GmbH, fostering an environment of innovation and discovery.

Conclusion

Steffen Koschmieder's contributions to the field of medicinal chemistry, particularly through his patent on bromodomain inhibitors, underscore his role as an influential inventor. His work continues to pave the way for new treatments in the fight against cancer and other related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…